Malta - angļu - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - rivaroxaban - film-coated tablet - rivaroxaban 15 mg - antithrombotic agents

Malta - angļu - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - rivaroxaban - film-coated tablet - rivaroxaban 20 mg - antithrombotic agents

Malta - angļu - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - zoledronic acid, monohydrate - concentrate for solution for infusion - zoledronic acid monohydrate 4 mg/5ml - drugs for treatment of bone diseases

Malta - angļu - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - zoledronic acid, monohydrate - solution for infusion - zoledronic acid monohydrate 5 mg - drugs for treatment of bone diseases

Malta - angļu - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - efavirenz - film-coated tablet - efavirenz 600 mg - antivirals for systemic use

Malta - angļu - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - capecitabine - film-coated tablet - capecitabine 150 mg - antineoplastic agents

Malta - angļu - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - capecitabine - film-coated tablet - capecitabine 500 mg - antineoplastic agents

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bortezomib, quantity: 3.5 mg - injection, powder for - excipient ingredients: mannitol - bortezomib sandoz, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy.,bortezomib sandoz, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma.,bortezomib sandoz is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease.,bortezomib sandoz in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

Malta - angļu - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - rivaroxaban - film-coated tablet - rivaroxaban 2.5 mg - antithrombotic agents

Malta - angļu - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - film-coated tablet - deferasirox 90 mg - all other therapeutic products